RxDoctor Payments Data

Melissa Prince

Adult Health · Scottsdale, AZNPI 1700914199

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,984 of the $6,495 with a category attached, or 61.3%. 30 manufacturers reported payments, led by IBSA Pharma Inc. at 35.2% of the total. Reporting peaked in 2023 at $2,482 and has fallen 96.1% since, to $96 in 2025. Among adult health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,495in general payments, 2019–2025

Across 204 payments — averaging $31.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • IBSA Pharma Inc.$2K
  • Insulet Corporation$696
  • Zealand Pharma US, Inc.$540
  • Corcept Therapeutics$488
  • Lilly USA, LLC$486
  • Amgen$267
  • plus $2K from 24 others

What the payments were for

  • Consulting fees$90014%
  • Speaking & faculty fees$1,60025%
  • Food & beverage$3,98461%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,495 in reported general payments places this provider in the 90th percentile of 314 adult health providers in Arizona.

See all adult health providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium30$2,084
Levothyroxine Sodium13$73

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$87$2,08430 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$132$7313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 314 adult health providers in Arizona.

Other adult health in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →